

Author: Vaccaro Vanja Melisi Davide Bria Emilio Cuppone Federica Ciuffreda Ludovica Pino Maria Simona Gelibter Alain Tortora Giampaolo Cognetti Francesco Milella Michele
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.15, Iss.10, 2011-10, pp. : 1183-1196
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content








Molecular Targets for Epigenetic Therapy of Cancer
Current Pharmaceutical Biotechnology, Vol. 10, Iss. 2, 2009-02 ,pp. :


Emerging cell-cycle inhibitors for pancreatic cancer therapy
Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. :